Ontario · updated monthly
Pharmacy prices, side by side, and what each clinic charges on top. We phone the pharmacies on the first of every month and put the date on it. No email, no gate.
Last verified 22 September 2026. See every check, with its date. Basal opened to patients in November 2026. This check slipped a cycle while the clinic was being set up, and the next one is due. We would rather say so than quietly restamp the date. Now that we have patients, the first of the month is a commitment, not an intention. Prices are what a cash-paying patient is quoted for a 4-week supply and change without notice. Cross-check us: glp1prices.ca is an independent tracker that phones 13 pharmacies across Canada and dates every entry. We have no affiliation with them and earn nothing from the link. We want you to be able to verify our numbers.
Generic semaglutide arrived in Canada in May 2026 and the price of the pen fell by roughly two-thirds. This is the number every other price on this page should be measured against.
| Pharmacy | 0.25–1 mg weekly 1 pen | 2 mg weekly 2 pens |
|---|---|---|
| Costco — no membership needed for the pharmacy counter | $88 | ~$176 |
| Walmart / No Frills | $95–110 | ~$190–220 |
| Shoppers Drug Mart / Rexall | $100–120 | ~$200–240 |
| PocketPills (delivered, $0 dispensing fee) | $20–40 under chain price | — |
In plain text. Generic semaglutide (Apo-Semaglutide) in Ontario, cash price per four weeks, checked 22 September 2026: Costco $88 for 0.25–1 mg weekly (one pen) and about $176 for 2 mg weekly (two pens), with no membership needed at the pharmacy counter. Walmart and No Frills $95–110 for one pen, about $190–220 for two. Shoppers Drug Mart and Rexall $100–120 for one pen, about $200–240 for two. PocketPills delivers for $20–40 under the chain price with no dispensing fee.
| Pharmacy | 1 mg weekly · 1 pen |
|---|---|
| Shoppers Drug Mart — Ontario | $104 |
| Costco Pharmacy — Quebec | $96.99 |
In plain text. SEVMIA is Apotex’s generic semaglutide, authorised by Health Canada on 29 June 2026 as the first generic semaglutide indicated for chronic weight management in Canada. Apo-Semaglutide, the cheaper product above, is the generic of Ozempic and carries a diabetes indication, so it is used off-label for weight. SEVMIA carries the weight-management indication itself. That matters for insurance: a private drug plan can consider a product indicated for weight management, and generally will not reimburse a diabetes-indicated product used off-label. Pricing is still thin — confirmed in only two provinces so far.
SEVMIA prices above were not phoned by Basal. They are taken from glp1prices.ca, an independent Canadian price tracker that phones pharmacies and dates every entry, confirmed by them in October 2026. We publish the source rather than restate someone else’s number as our own.
| Product | Status | Price |
|---|---|---|
| Orforglipron (oral) — Lilly | Under Health Canada review | no Canadian price |
| Oral semaglutide for weight management | Under review | no Canadian price |
In plain text. Two products are not yet authorised for sale in Canada and therefore have no Canadian price: orforglipron, an oral GLP-1 from Eli Lilly, is under Health Canada review (the full status, with dates); oral semaglutide for weight management is also under review. Neither can be prescribed in Canada today, and authorisation is not guaranteed.
Neither has been authorised for sale by Health Canada, and authorisation is not guaranteed. Orforglipron was approved in the United States in April 2026 and sells there for roughly US$149 to US$349 a month depending on dose; Health Canada accepted it into review in January 2026. We are not promoting either product and cannot prescribe what is not approved. We will publish the Canadian price here the day one exists — that is the only thing we are promising.
Apotex publishes a wholesale list price of $78.14 per 4-week supply; the rest is the pharmacy's dispensing fee and margin. Six further semaglutide generics are under Health Canada review, so expect this table to get cheaper.
| Dose | List | Costco |
|---|---|---|
| 2.5–5 mg weekly | ~$300 | $326 |
| 7.5–10 mg weekly | ~$420 | $454 |
| 12.5–15 mg weekly | ~$540 | $582 |
In plain text. Tirzepatide is sold in Canada as Mounjaro and Zepbound, brand only with no generic, per four weeks, checked 22 September 2026: 2.5–5 mg weekly about $300 list and $326 at Costco; 7.5–10 mg weekly about $420 list and $454 at Costco; 12.5–15 mg weekly about $540 list and $582 at Costco.
Eli Lilly runs separate patient support programs for Mounjaro and Zepbound — they are not interchangeable, so ask the pharmacy which one applies to the product you are actually dispensed. Either reduces the cost by roughly 25–40% for eligible patients, with a further reduction for low income.
Most Canadian telehealth clinics quote one bundled number that includes the medication. Because the pharmacy price is public, the care fee can be worked out by subtraction — that's the third column. It is our arithmetic, not their disclosure.
| Clinic | You pay | Care fee, by subtraction | Notes |
|---|---|---|---|
| Basal + your pharmacy | $29 + pharmacy | $29 | Fee only. Medication bought at the pharmacy you choose, at their price. $29 is our founding price for the first 100 patients, held for as long as they stay. |
| Felix | $149 · $298 at 2 mg | $61 · $122 | Bundled. The fee doubles when the dose does. |
| Hims | $149 + $99 first visit | $61 | Bundled. |
| Rocky | $149 + $60 program fee | $121 | Program fee shown separately, to their credit. |
| BirchRx | $149, then $199 | $61 → $111 | Bundled. Rises after the first month. |
| Maple | $69 per consult + brand $270–320 | $69 | Brand medication. |
In plain text. Published Canadian clinic prices for generic semaglutide, September 2026, with the care fee derived by subtracting the pharmacy price: Basal charges $29 a month for the nurse practitioner review only, and the patient buys the medication at their own pharmacy, so the care fee is $29. Felix charges $149 a month at 1 mg and $298 at 2 mg, medication bundled in, so the care fee is about $61 at 1 mg and $122 at 2 mg — the fee doubles when the dose does. Hims charges $149 a month plus a $99 first visit, bundled, a care fee of about $61.
Clinic prices as published on each company's own website on 20–22 September 2026. "Care fee, by subtraction" = their bundled price minus the Costco pen price for the same dose. Where a clinic publishes its fee separately we use their number.
This page is published by Basal, the company. It is not an advertisement by, or a statement of, any nurse practitioner.
One year, one patient
Basal — 12 × $29 + 12 pens at Costco
Felix — 12 × $149, medication included
Our fee stays the same at every dose. Felix's doubles at 2 mg, and over a year at 2 mg the gap between Basal and Felix is $1,116.
The Receipt shows all of it itemized, eight pages, free.
Including us. If a clinic won't answer these in writing, that is the answer.
Basal's answers: the pharmacy's price plus $29 · yes, any pharmacy in Ontario · no · no, never before your nurse practitioner approves you · no, and never.
Your drug plan
If you have a drug plan through work, it may pay for some of this. Whether it does turns on something most clinics never mention — which product is on the prescription.
| Product | Health Canada indication | For a weight-management claim |
|---|---|---|
| Ozempic · generic semaglutide · Mounjaro | Type 2 diabetes | Generally not covered — wrong indication |
| Wegovy · Sevmia · Zepbound | Chronic weight management | The ones a plan can consider |
In plain text. A private drug plan decides on the Health Canada indication, not on the molecule. Ozempic, generic semaglutide and Mounjaro are indicated for type 2 diabetes, so a weight-management claim is generally refused — wrong indication. Wegovy, Sevmia and Zepbound are indicated for chronic weight management and are the products a plan can consider.
The cheapest option at the pharmacy is a diabetes-indicated generic, and for most people paying cash that is the right answer. But it is the wrong product to put in front of an insurer for weight management. If coverage matters more to you than the sticker price, say so at intake — it changes which product your nurse practitioner considers.
Manulife, Sun Life, Canada Life and GreenShield administer whatever your employer bought. Two people with the same insurer can get different answers. Nobody can tell you what your plan covers by looking at the logo on your card — including us.
Phone the number on your card and ask exactly this: “Is semaglutide or tirzepatide covered for chronic weight management on my plan, and do you need a prior-authorisation form?”
Where a plan does consider it, the common conditions are a documented BMI of 30 or more, or 27 or more with a weight-related condition; sometimes a recorded attempt at diet and exercise first; sometimes a cheaper medication first. Criteria vary by contract and are often not published.
Your nurse practitioner completes the prior-authorisation form and any supporting letter. $89, once, and it sits outside the monthly fee. Approval is never guaranteed and the decision is your insurer’s.
And we have no reason not to try. We don’t sell the medication, so coverage costs us nothing. Every clinic that bundles the drug into its price loses its margin when your plan pays — which is why they rarely bring it up.
How this page is maintained
On the first of every month we call five Ontario pharmacies for a cash quote at each dose, and re-read every clinic's public pricing page. The date at the top is the date we did it. When a price moves, this page moves — including when it moves against us.
Found a number that's wrong, or a better price than the ones here? Tell us and we'll correct it: [email protected].
One email a month at most, and we'll tell you when Basal opens in Ontario. Nothing else.
People search for this medication under half a dozen names, and the names are not interchangeable even when the drug is. Here is what each one actually refers to in Canada.
Why the name matters more than the molecule. A private drug plan decides on the authorised indication, not the ingredient. That is why the same semaglutide is refused as Ozempic and considered as Wegovy. The full indication table is above.
Sources
Every price on this page is a counter check or a clinic’s own published figure, dated in the verification log. Everything else rests on these:
Update log
The next pharmacy check is overdue. We publish the date rather than restamp it. See the verification log.
Related